Cargando…
Predicting GPR40 Agonists with A Deep Learning‐Based Ensemble Model
Recent studies have identified G protein‐coupled receptor 40 (GPR40) as a promising target for treating type 2 diabetes mellitus, and GPR40 agonists have several superior effects over other hypoglycemic drugs, including cardiovascular protection and suppression of glucagon levels. In this study, we...
Autores principales: | Yang, Jiamin, Jiang, Chen, Chen, Jing, Qin, Lu‐Ping, Cheng, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661831/ https://www.ncbi.nlm.nih.gov/pubmed/37404062 http://dx.doi.org/10.1002/open.202300051 |
Ejemplares similares
-
Identification of Crocetin as a Dual Agonist of GPR40 and GPR120 Responsible for the Antidiabetic Effect of Saffron
por: Zhao, Xiaodi, et al.
Publicado: (2023) -
EnsembleSplice: ensemble deep learning model for splice site prediction
por: Akpokiro, Victor, et al.
Publicado: (2022) -
Fasiglifam (TAK-875), a G Protein-Coupled Receptor 40 (GPR40) Agonist, May Induce Hepatotoxicity through Reactive Oxygen Species Generation in a GPR40-Dependent Manner
por: Kim, MinJeong, et al.
Publicado: (2018) -
Sports Economic Operation Index Prediction Model Based on Deep Learning and Ensemble Learning
por: Yang, Chuangjian, et al.
Publicado: (2022) -
Deep learning-based classification model for GPR151 activator activity prediction
por: Xu, Huangchao, et al.
Publicado: (2023)